These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Maternal serum screening for fetal trisomy 18: benefits of patient-specific risk protocol. Hogge WA; Fraer L; Melegari T Am J Obstet Gynecol; 2001 Aug; 185(2):289-93. PubMed ID: 11518881 [TBL] [Abstract][Full Text] [Related]
5. Maternal serum screening for fetal Down syndrome in women less than 35 years of age using alpha-fetoprotein, hCG, and unconjugated estriol: a prospective 2-year study. Phillips OP; Elias S; Shulman LP; Andersen RN; Morgan CD; Simpson JL Obstet Gynecol; 1992 Sep; 80(3 Pt 1):353-8. PubMed ID: 1379701 [TBL] [Abstract][Full Text] [Related]
6. Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. Haddow JE; Palomaki GE; Knight GJ; Cunningham GC; Lustig LS; Boyd PA N Engl J Med; 1994 Apr; 330(16):1114-8. PubMed ID: 7510852 [TBL] [Abstract][Full Text] [Related]
7. Preliminary evidence for associations between second-trimester human chorionic gonadotropin and unconjugated oestriol levels with pregnancy outcome in Down syndrome pregnancies. Benn PA Prenat Diagn; 1998 Apr; 18(4):319-24. PubMed ID: 9602476 [TBL] [Abstract][Full Text] [Related]
8. A retrospective evaluation of maternal serum screening for the detection of fetal aneuploidy. Suzumori K; Tanemura M; Murakami I; Okada S; Natori M; Tanaka M; Takagi T; Sato A Prenat Diagn; 1997 Sep; 17(9):861-6. PubMed ID: 9316131 [TBL] [Abstract][Full Text] [Related]
9. Estimates for the sensitivity and false-positive rates for second trimester serum screening for Down syndrome and trisomy 18 with adjustment for cross-identification and double-positive results. Benn PA; Ying J; Beazoglou T; Egan JF Prenat Diagn; 2001 Jan; 21(1):46-51. PubMed ID: 11180240 [TBL] [Abstract][Full Text] [Related]
10. Serum markers for Down's syndrome in relation to number of previous births and maternal age. Wald NJ; Watt HC Prenat Diagn; 1996 Aug; 16(8):699-703. PubMed ID: 8878278 [TBL] [Abstract][Full Text] [Related]
11. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital. Lamlertkittikul S; Chandeying V J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410 [TBL] [Abstract][Full Text] [Related]
12. Major fetal abnormalities associated with positive screening tests for Smith-Lemli-Opitz syndrome (SLOS). Craig WY; Haddow JE; Palomaki GE; Roberson M Prenat Diagn; 2007 May; 27(5):409-14. PubMed ID: 17286308 [TBL] [Abstract][Full Text] [Related]
13. [Noninvasive serum test for prenatal detection of Down syndrome, other chromosome abnormalities and open neural tube defects--a prospective study]. Zwahr C; Voss P; Kistner G Geburtshilfe Frauenheilkd; 1994 Jun; 54(6):355-61. PubMed ID: 7522195 [TBL] [Abstract][Full Text] [Related]
14. The identification of risk of spontaneous fetal loss through second-trimester maternal serum screening. Huang T; Owolabi T; Summers AM; Meier C; Wyatt PR Am J Obstet Gynecol; 2005 Aug; 193(2):395-403. PubMed ID: 16098861 [TBL] [Abstract][Full Text] [Related]
15. Maternal serum markers for Down's syndrome pregnancies. Chew S; Anandakumar C; Ratnam SS Singapore Med J; 1995 Aug; 36(4):417-23. PubMed ID: 8919160 [TBL] [Abstract][Full Text] [Related]
16. [Prenatal serum screening of aneuploidy and of neural tube defects in the second trimester of pregnancy among the population of Luxembourg. Evaluation of risk by the triple test (AFP+THCG+UE3)]. Thix J Bull Soc Sci Med Grand Duche Luxemb; 1997; 134(1):25-9. PubMed ID: 9303823 [TBL] [Abstract][Full Text] [Related]
17. [Screening for Down syndrome using triple marker testing in the second trimester of pregnancy]. Lesin J; Skrablin S; Durić K; Suchanek E; Muzinić D; Kalafatić D; Kuvacić I; Zlopasa G; Plavec A Lijec Vjesn; 2003; 125(3-4):55-60. PubMed ID: 12899094 [TBL] [Abstract][Full Text] [Related]
18. Second-trimester maternal serum alpha-fetoprotein and human chorionic gonadotrophin screening for Down's syndrome in Hong Kong. Lam YH; Ghosh A; Tang MH; Tang LC; Lee CP; Sin SY; Ho PK Prenat Diagn; 1998 Jun; 18(6):585-89. PubMed ID: 9664604 [TBL] [Abstract][Full Text] [Related]
19. [Maternal serum screening for Down syndrome and neural tube defects]. van Rijn M; Christiaens GC; van der Schouw YT; Hagenaars AM; de Pater JM; Visser GH Ned Tijdschr Geneeskd; 1998 Feb; 142(8):409-15. PubMed ID: 9562776 [TBL] [Abstract][Full Text] [Related]
20. [Evaluation of Down's syndrome screening methods using maternal serum biochemistry in the second trimester pregnancy]. Yu DY; Fu P; Zhang ZH; Wang F; Han MY; Ren HY; Zhao W; Zhang K; Li S; Jiang N Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2011 Jun; 28(3):332-5. PubMed ID: 21644235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]